{
 "drug": "Lamotrigine Tablet, Extended Release",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "04/29/2026",
 "dayN": 118,
 "cat": "Neurology",
 "companies": [
  "Par Health, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "04/29/2026",
   "update_type": "New",
   "initial_posting_date": "04/29/2026",
   "package_ndc": "49884-563-11",
   "generic_name": "Lamotrigine Tablet, Extended Release",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "04/29/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)",
   "company_name": "Par Health, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/29/2026",
   "update_type": "New",
   "initial_posting_date": "04/29/2026",
   "package_ndc": "49884-561-11",
   "generic_name": "Lamotrigine Tablet, Extended Release",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA201791"
    ],
    "brand_name": [
     "LAMOTRIGINE EXTENDED RELEASE"
    ],
    "generic_name": [
     "LAMOTRIGINE EXTENDED RELEASE"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "49884-561",
     "49884-562",
     "49884-563",
     "49884-564",
     "49884-604",
     "49884-605"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LAMOTRIGINE"
    ],
    "rxcui": [
     "850087",
     "850091",
     "900156",
     "900164",
     "1098608",
     "1146690"
    ],
    "spl_id": [
     "9c5e0c2a-800e-47e9-a26b-582b98a05957"
    ],
    "spl_set_id": [
     "fb59c76a-9b6f-40ea-ac3a-58c3195c4377"
    ],
    "package_ndc": [
     "49884-561-11",
     "49884-561-01",
     "49884-561-05",
     "49884-562-11",
     "49884-562-01",
     "49884-562-05",
     "49884-563-11",
     "49884-563-01",
     "49884-563-05",
     "49884-564-11",
     "49884-564-01",
     "49884-564-05",
     "49884-604-11",
     "49884-604-01",
     "49884-604-05",
     "49884-605-11",
     "49884-605-01",
     "49884-605-05"
    ],
    "nui": [
     "N0000175753",
     "N0000008486",
     "N0000175751",
     "N0000187061",
     "N0000000191"
    ],
    "pharm_class_epc": [
     "Anti-epileptic Agent [EPC]",
     "Mood Stabilizer [EPC]"
    ],
    "pharm_class_pe": [
     "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_moa": [
     "Organic Cation Transporter 2 Inhibitors [MoA]",
     "Dihydrofolate Reductase Inhibitors [MoA]"
    ],
    "unii": [
     "U3H27498KS"
    ]
   },
   "update_date": "04/29/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)",
   "company_name": "Par Health, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/29/2026",
   "update_type": "New",
   "initial_posting_date": "04/29/2026",
   "package_ndc": "49884-562-11",
   "generic_name": "Lamotrigine Tablet, Extended Release",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "04/29/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)",
   "company_name": "Par Health, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/29/2026",
   "update_type": "New",
   "initial_posting_date": "04/29/2026",
   "package_ndc": "49884-605-11",
   "generic_name": "Lamotrigine Tablet, Extended Release",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA201791"
    ],
    "brand_name": [
     "LAMOTRIGINE EXTENDED RELEASE"
    ],
    "generic_name": [
     "LAMOTRIGINE EXTENDED RELEASE"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "49884-605",
     "49884-561",
     "49884-562",
     "49884-563",
     "49884-564",
     "49884-604"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LAMOTRIGINE"
    ],
    "rxcui": [
     "850087",
     "850091",
     "900156",
     "900164",
     "1098608",
     "1146690"
    ],
    "spl_id": [
     "9c5e0c2a-800e-47e9-a26b-582b98a05957"
    ],
    "spl_set_id": [
     "fb59c76a-9b6f-40ea-ac3a-58c3195c4377"
    ],
    "package_ndc": [
     "49884-561-11",
     "49884-561-01",
     "49884-561-05",
     "49884-562-11",
     "49884-562-01",
     "49884-562-05",
     "49884-563-11",
     "49884-563-01",
     "49884-563-05",
     "49884-564-11",
     "49884-564-01",
     "49884-564-05",
     "49884-604-11",
     "49884-604-01",
     "49884-604-05",
     "49884-605-11",
     "49884-605-01",
     "49884-605-05"
    ],
    "nui": [
     "N0000175753",
     "N0000008486",
     "N0000175751",
     "N0000187061",
     "N0000000191"
    ],
    "pharm_class_epc": [
     "Anti-epileptic Agent [EPC]",
     "Mood Stabilizer [EPC]"
    ],
    "pharm_class_pe": [
     "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_moa": [
     "Organic Cation Transporter 2 Inhibitors [MoA]",
     "Dihydrofolate Reductase Inhibitors [MoA]"
    ],
    "unii": [
     "U3H27498KS"
    ]
   },
   "update_date": "04/29/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)",
   "company_name": "Par Health, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/29/2026",
   "update_type": "New",
   "initial_posting_date": "04/29/2026",
   "package_ndc": "49884-564-11",
   "generic_name": "Lamotrigine Tablet, Extended Release",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "04/29/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)",
   "company_name": "Par Health, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/29/2026",
   "update_type": "New",
   "initial_posting_date": "04/29/2026",
   "package_ndc": "49884-604-11",
   "generic_name": "Lamotrigine Tablet, Extended Release",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA201791"
    ],
    "brand_name": [
     "LAMOTRIGINE EXTENDED RELEASE"
    ],
    "generic_name": [
     "LAMOTRIGINE EXTENDED RELEASE"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "49884-604",
     "49884-561",
     "49884-562",
     "49884-563",
     "49884-564",
     "49884-605"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "LAMOTRIGINE"
    ],
    "rxcui": [
     "850087",
     "850091",
     "900156",
     "900164",
     "1098608",
     "1146690"
    ],
    "spl_id": [
     "9c5e0c2a-800e-47e9-a26b-582b98a05957"
    ],
    "spl_set_id": [
     "fb59c76a-9b6f-40ea-ac3a-58c3195c4377"
    ],
    "package_ndc": [
     "49884-561-11",
     "49884-561-01",
     "49884-561-05",
     "49884-562-11",
     "49884-562-01",
     "49884-562-05",
     "49884-563-11",
     "49884-563-01",
     "49884-563-05",
     "49884-564-11",
     "49884-564-01",
     "49884-564-05",
     "49884-604-11",
     "49884-604-01",
     "49884-604-05",
     "49884-605-11",
     "49884-605-01",
     "49884-605-05"
    ],
    "nui": [
     "N0000175753",
     "N0000008486",
     "N0000175751",
     "N0000187061",
     "N0000000191"
    ],
    "pharm_class_epc": [
     "Anti-epileptic Agent [EPC]",
     "Mood Stabilizer [EPC]"
    ],
    "pharm_class_pe": [
     "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_moa": [
     "Organic Cation Transporter 2 Inhibitors [MoA]",
     "Dihydrofolate Reductase Inhibitors [MoA]"
    ],
    "unii": [
     "U3H27498KS"
    ]
   },
   "update_date": "04/29/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)",
   "company_name": "Par Health, Inc.",
   "status": "To Be Discontinued"
  }
 ]
}